Comprehensive multimodal management of borderline resectable pancreatic cancer: Current status and progress

Borderline resectable pancreatic cancer (BRPC) is a complex clinical entity with specific biological features. Criteria for resectability need to be assessed in combination with tumor anatomy and oncology. Neoadjuvant therapy (NAT) for BRPC patients is associated with additional survival benefits. R...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Hong-Yu, Li, Jin-Wei, Li, Jin-Zheng, Zhai, Qi-Long, Ye, Jing-Yuan, Zheng, Si-Yuan, Fang, Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988647/
https://www.ncbi.nlm.nih.gov/pubmed/36896309
http://dx.doi.org/10.4240/wjgs.v15.i2.142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9988647/
https://www.ncbi.nlm.nih.gov/pubmed/36896309
http://dx.doi.org/10.4240/wjgs.v15.i2.142

Ejemplares similares